Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.
-
Upload
logan-lane -
Category
Documents
-
view
221 -
download
0
Transcript of Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.
![Page 1: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/1.jpg)
Immune Response and Fighting Brain Cancer
with Gene Therapy
Abbie Hunt
November 10, 2009
![Page 2: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/2.jpg)
Overview
Glioblastoma multiforme (GBM) Dendritic Cells (DC) Fms-like tyrosine kinase 3 ligand (Flt3L) Toll-like receptors (TLR) Bone-marrow derived DCs (BMDC) High-mobility-group box 1 (HMGB1)
![Page 3: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/3.jpg)
Cell lines, etc.
Challengers Ad-TK Ad-Flt3L Ad0
Returning Champions GL26 GL261 B16-F10 LLc1
![Page 4: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/4.jpg)
Mice!
Female C57BL/6 MyD88-/-
TLR4-/-
WT Chimeric
WT and GFP+/+
WT and TLR2-/-
http://brainwindows.files.wordpress.com/2008/10/image-gfp-mouse-crop-copy.jpg
![Page 5: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/5.jpg)
Glioma Models
GL26 GL261 B16-F10
Ad0 Ad-Flt3L + Ad0 Ad-TK + Ad0 Ad-Flt3L + Ad-TK
GCV
Saline
Rechallenged
![Page 6: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/6.jpg)
T cells necessary in tumor regression
![Page 7: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/7.jpg)
DCs come from bone marrow
![Page 8: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/8.jpg)
TLR2 expression by BMDC necessary in tumor regression
![Page 9: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/9.jpg)
HMGB1 mediates TLR2-dependent glioma tumor regression
Increased levels of HMGB1 from GL26 treated with Ad-TK+GCV in vitro
Increased serum levels in mice Blocked with glycyrrhizin or specific anti-
HMGB1 antibodies
![Page 10: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/10.jpg)
HMGB1 released from tumor cells with Ad-TK+GCV, chemotherapy, or radiation therapy
![Page 11: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/11.jpg)
Ad-TK(+GCV) + Ad-Flt3L = Survival and Increased HMGB1
![Page 12: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/12.jpg)
Recap
T cells necessary in tumor regression DCs come from bone marrow TLR2 expression by BMDC necessary in t.r. HMGB1 mediates TLR2-dependent glioma t.r. HMGB1 released from tumor cells with Ad-
TK+GCV, chemotherapy, or radiation therapy Ad-TK (+GCV) and Ad-Flt3L therapy results
in GL261 and B16-F10 tumor regression and increased HMGB1 levels
![Page 13: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/13.jpg)
![Page 14: Immune Response and Fighting Brain Cancer with Gene Therapy Abbie Hunt November 10, 2009.](https://reader036.fdocuments.us/reader036/viewer/2022062518/56649de55503460f94adcb03/html5/thumbnails/14.jpg)
References 1. Curtin J.F., Liu N., Candolfi M., et al. 2009. HMB1 Mediate
Endogenous TLR2 Activation and Brain Tumor Regression. PLoS Medicine. 6(1): 84-104.
2. Southgate T., Kroeger K.M., Liu C., Lowenstein P.R. (2008). Gene transfer into meural cells in vivo using adenoviral vectors. Published online at Wiley Interscience. Available online at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659706/ Accessed 11/4/09.
3. Sandmair A., Vapalahti M., Yla-Herttuala S. (2000). Adenovirus-Mediated Herpes Simplex Thymidine Kinase Gene Therapy for Brain Tumors. Cancer Gene Therapy: Past Achievements and Future Challenges. Plenum Publishers, New York. 163-170.
4. Stevenson, P. Immunological Memory. The Australian Naturopathic Network. Revised 5/18/2002. Available online at http://www.ann.com.au/MedSci/immunolo.htm Accessed 11/3/09.
5. Multitudes of Wikipedia pages